Allianz SE (ALIZY) Stock Forecast and Price Target (2026)

Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. That is the situation with ALIZY. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model rather than a consensus.

At roughly EUR 420 per Frankfurt share, Allianz is valued at around EUR 160 billion and trades near 14 to 15 times 2025 core earnings and closer to 13 times what the first-half run rate implies, with a dividend yield around 4%. Those multiples sit at the upper end of where European composite insurers have traded historically, reflecting record profit, a ~20% core return on equity and strong capital, but they are below many US insurers and asset managers. Allianz does not report a conventional revenue line; total business volume (premiums plus asset-management fees) is the closest equivalent, so price-to-sales comparisons with non-insurers are not meaningful.

For the fiscal year ending Dec 2026, the 5 analysts publishing estimates on ALIZY expect earnings of $3.55 per share (+5.3% on the year before) and revenue of 185.5 billion EUR (-0.8%).

Estimates are the most widely published forecast there is: many more analysts model a company's earnings than publish a price target on it. They are also revised constantly, and the direction of those revisions into a report is often more informative than the level. Allianz SE next reports on November 12, 2026, which is when these figures get tested against actual results.

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering ALIZY do not put out a 2030 number. Anything presenting one is extrapolating a growth rate rather than reporting research, and a figure produced that way tells you about the assumption chosen, not about the company.

The furthest-out consensus that exists is for the fiscal year ending Dec 2027: analysts expect earnings of $3.80 per share, +7.0% on the fiscal year ending Dec 2026 estimate of $3.55. Beyond that, nobody publishes estimates, so any later number is an extrapolation.

On the figures we hold as of October 2026, ALIZY trades at about 13.6 times trailing earnings and 12.8 times forward earnings. A forward multiple below the trailing one means the market expects earnings to grow, and the size of that gap is roughly how much growth is already in the price.

That is the more useful frame for a ten-year question. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether Allianz SE can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

In short: the drivers cited most often are Property-Casualty pricing and underwriting discipline, PIMCO and the asset-management flow cycle, Life/Health repricing and capital-light growth. The risk cited most often against it is natural catastrophes are the most visible risk: a severe European storm or flood season, wildfire or hurricane losses can push the P&C combined ratio up several points in a single quarter.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the ALIZY is it a buy page. This page deliberately stops at the numbers.